Nisian Hughes/DigitalVision via Getty Images Main Thesis Ponce Financial Group, Inc. ( PDLB ) valuation, as I will see, is mostly from its preferred stock redemption and elevated perpetual growth estimates. The company lacks solid profitability and, even with elevated capital ratios, has to decrease its riskiness due to elevated loan levels compared to its peers. The declining fiscal health of low...
Nisian Hughes/DigitalVision via Getty Images Main Thesis Ponce Financial Group, Inc. ( PDLB ) valuation, as I will see, is mostly from its preferred stock redemption and elevated perpetual growth estimates. The company lacks solid profitability and, even with elevated capital ratios, has to decrease its riskiness due to elevated loan levels compared to its peers. The declining fiscal health of low-income households, harsher business environments for small businesses, and political winds may slow the company’s growth, while bull scenarios are limited to an improbable improvement in the health of small businesses and low-income individuals, and/or multiple expansions. The Bank Ponce Financial Group is the bank holding for Ponce Bank, a Community Development Financial Institution (CDIF) and a Minority Depository Institution (MDI), giving loans predominantly to Small-Medium Sized Businesses (SMB) and Low-to-Moderate Income ( (LMI)) neighborhoods. The bank is headquartered in the Bronx, New York, and its loans are mostly given to individuals there and in Harlem. The bank was founded in 1960 by Puerto Rican migrants as a local savings association, and it currently holds $3.22 billion in assets, $2.60 billion in loans, and $2.05 billion in deposits, as stated in their latest 8-K filing . Preferred Stock Situation As mentioned in their 8-K, on December 20, 2024, Ponce Financial Group entered in an Emergency Capital Investment Program (ECIP) securities purchase option agreement with the US Department of the Treasury, allowing the company to repurchase the Preferred Shares at a steep discount. Currently, the preferred shares amount to $225 Million, and have a dividend of 0.5%. To be eligible for repurchase, the company needs at least 60% of its loans to be categorized as “deep impact” for at least 16 quarters. The company claims to have achieved an 82% rate of deep impact loans for 14 consecutive quarters, implying that the repurchase could occur as soon as 3Q 2026. In case t...
(RTTNews) - While reporting financial results for the fourth quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) initiated its adjusted earnings and sales growth guidance for the first quarter, and for the full-year 2026. For the first quarter, the company estimates adjusted earnings in a range of $0.78 to $0.80 per share on net sales growth of about 10.5 to 12.0 percent, w...
(RTTNews) - While reporting financial results for the fourth quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) initiated its adjusted earnings and sales growth guidance for the first quarter, and for the full-year 2026. For the first quarter, the company estimates adjusted earnings in a range of $0.78 to $0.80 per share on net sales growth of about 10.5 to 12.0 percent, with organic net sales growth of 8.5 to 10.0 percent. On average, analysts polled expect earnings of $0.80 per share on revenue growth of 11.57 percent to $5.20 billion for the quarter. Analysts' estimates typically exclude special items. Looking ahead to fiscal 2026, the company now projects adjusted earnings in a range of $3.43 to $3.49 per share on net sales growth of about 10.5 to 11.5 percent, with organic net sales growth of 10 to 11 percent. The Street is looking for earnings of $3.47 per share on revenue growth of 11.55 percent to $22.39 billion for the quarter. In Wednesday's pre-market trading, BSX is trading on the NYSE at $90.00, down $1.59 or 1.74 percent. For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Worries about artificial intelligence disrupting the software business are overblown, Nvidia Chief Executive Jensen Huang said. "There's this notion that the software industry is in decline and will be replaced by AI," Huang said late Tuesday at an event hosted by Cisco, hours after a selloff in U.S. software stocks. "There's a whole bunch of software companies whose stock prices are under a lot o...
Worries about artificial intelligence disrupting the software business are overblown, Nvidia Chief Executive Jensen Huang said. "There's this notion that the software industry is in decline and will be replaced by AI," Huang said late Tuesday at an event hosted by Cisco, hours after a selloff in U.S. software stocks. "There's a whole bunch of software companies whose stock prices are under a lot of pressure because somehow AI is going to replace them," Huang said.
Worries about artificial intelligence disrupting the software business are overblown, Nvidia Chief Executive Jensen Huang said. "There's this notion that the software industry is in decline and will be replaced by AI," Huang said late Tuesday at an event hosted by Cisco, hours after a selloff in U.S. software stocks. "There's a whole bunch of software companies whose stock prices are under a lot o...
Worries about artificial intelligence disrupting the software business are overblown, Nvidia Chief Executive Jensen Huang said. "There's this notion that the software industry is in decline and will be replaced by AI," Huang said late Tuesday at an event hosted by Cisco, hours after a selloff in U.S. software stocks. "There's a whole bunch of software companies whose stock prices are under a lot of pressure because somehow AI is going to replace them," Huang said.
Joe Raedle/Getty Images News Boston Scientific ( BSX ) lost ~9% in the premarket on Wednesday after the MedTech giant indicated an underwhelming outlook for 2026 with its Q4 2025 results, which, however, beat Street forecasts thanks to an all-around performance from its segments. The Marlborough, Massachusetts-based company reported $0.80 of adjusted EPS on $5.3B in revenue, beating the consensus ...
Joe Raedle/Getty Images News Boston Scientific ( BSX ) lost ~9% in the premarket on Wednesday after the MedTech giant indicated an underwhelming outlook for 2026 with its Q4 2025 results, which, however, beat Street forecasts thanks to an all-around performance from its segments. The Marlborough, Massachusetts-based company reported $0.80 of adjusted EPS on $5.3B in revenue, beating the consensus by $0.02 and $10M with ~16% YoY and ~14% YoY growth, respectively. Its full-year revenue and adjusted EPS reached $20.1B and $3.06 with ~20% YoY and ~22% YoY growth, respectively. However, for 2026, Boston Scientific ( BSX ) fell short of ~11.6% YoY growth and $3.47 of EPS in the consensus at the midpoint, forecasting 10.5% YoY - 11.5% YoY net sales growth on a reported basis and $3.43 - $3.49 in adjusted EPS for 2026, respectively. For Q1 2026, the company expects to record $0.78 - $0.80 of adjusted EPS on 10.5% - 12.0% YoY net sales growth compared to $0.80 and ~11.6% YoY growth projected by analysts, respectively. As for individual segments, Boston Scientific ( BSX ) reported $760M and $717M in net sales from its Endoscopy and Urology segments in Q4, implying ~11% YoY and ~14% YoY growth compared to $757.5M and $717M in the consensus, respectively, according to Bloomberg data. Meanwhile, its MedSurg and Cardiovascular segments added $1.8B and $3.5B in net sales to the topline with ~12% YoY and ~18% YoY growth, respectively. The company’s quarterly gross and operating margins improved to ~70% and ~16%, respectively, compared to ~68% and ~15% in the prior period. "2025 was another exceptional year for Boston Scientific, with our global teams delivering differentiated innovation and high performance that enabled us to exceed our goals," CEO Mike Mahoney remarked ahead of the earnings call at 8:00 a.m. ET. More on Boston Scientific Boston Scientific: Adding Another Growth Engine With Penumbra Boston Scientific's Bet On Penumbra Isn't To My Liking Boston Scientific: Reclaimin...
Qualcomm Incorporated (NASDAQ:QCOM) will release earnings for the first quarter after the closing bell on Wednesday, Feb. 4. Analysts expect the company to report earnings of $3.40 per share. That's down from $3.41 per share in the year-ago period. The consensus estimate for Qualcomm's quarterly revenue is $12.18 billion (it reported $11.67 billion last year), according to Benzinga Pro. Ahead of q...
Qualcomm Incorporated (NASDAQ:QCOM) will release earnings for the first quarter after the closing bell on Wednesday, Feb. 4. Analysts expect the company to report earnings of $3.40 per share. That's down from $3.41 per share in the year-ago period. The consensus estimate for Qualcomm's quarterly revenue is $12.18 billion (it reported $11.67 billion last year), according to Benzinga Pro. Ahead of quarterly earnings, Cantor Fitzgerald analyst C.J. Muse, on Monday, maintained Qualcomm with a Neutral rating and cut the price target from $185 to $160. With the recent buzz around Qualcomm, some investors may be eyeing potential gains from the company's dividends too. As of now, Qualcomm has an annual dividend yield of 2.42%, which is a quarterly dividend amount of 89 cents per share ($3.56 a year). To figure out how to earn $500 monthly from Qualcomm, we start with the yearly target of $6,000 ($500 x 12 months). Next, we take this amount and divide it by Qualcomm's $3.56 dividend: $6,000 / $3.56 = 1,685 shares. So, an investor would need to own approximately $247,998 worth of Qualcomm, or 1,685 shares to generate a monthly dividend income of $500. Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $3.56 = 337 shares, or $49,600 to generate a monthly dividend income of $100. Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time. The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change. For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60). Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40). Further, the dividend payment itself can also chan...
Seeking Alpha (Seeking Alpha) Seeking Alpha (Seeking Alpha) Seeking Alpha (Seeking Alpha) Seeking Alpha (Seeking Alpha) Seeking Alpha (Seeking Alpha) Seeking Alpha (Seeking Alpha) More on Yum! Brands Yum! Brands: Don't Count On Pizza Hut Sale To Boost This Indebted Business Yum! Brands, Pizza Hut And The Billion-Dollar Slice: A Sale Could Unlock Tremendous Value Yum! Brands: Tasty Fundamentals, Bu...
Seeking Alpha (Seeking Alpha) Seeking Alpha (Seeking Alpha) Seeking Alpha (Seeking Alpha) Seeking Alpha (Seeking Alpha) Seeking Alpha (Seeking Alpha) Seeking Alpha (Seeking Alpha) More on Yum! Brands Yum! Brands: Don't Count On Pizza Hut Sale To Boost This Indebted Business Yum! Brands, Pizza Hut And The Billion-Dollar Slice: A Sale Could Unlock Tremendous Value Yum! Brands: Tasty Fundamentals, But Valuation And Technicals Are Unappetizing Yum! Brands tops same-store sales expectations as Taco Bell does the heavy lifting Yum! Brands Non-GAAP EPS of $1.73 misses by $0.03, revenue of $2.51B beats by $60M
Rockline Wealth Management LLC lifted its stake in shares of Alphabet Inc. (NASDAQ:GOOG - Free Report) by 5.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 61,794 shares of the information services provider's stock after purchasing an additional 3,224 shares during the period. Alphabet comprises 3.1% ...
Rockline Wealth Management LLC lifted its stake in shares of Alphabet Inc. (NASDAQ:GOOG - Free Report) by 5.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 61,794 shares of the information services provider's stock after purchasing an additional 3,224 shares during the period. Alphabet comprises 3.1% of Rockline Wealth Management LLC's investment portfolio, making the stock its 8th biggest position. Rockline Wealth Management LLC's holdings in Alphabet were worth $15,050,000 as of its most recent filing with the Securities & Exchange Commission. Other hedge funds have also recently modified their holdings of the company. Manning & Napier Advisors LLC acquired a new stake in Alphabet during the 3rd quarter worth $32,000. IFS Advisors LLC lifted its stake in shares of Alphabet by 400.0% in the second quarter. IFS Advisors LLC now owns 150 shares of the information services provider's stock worth $27,000 after buying an additional 120 shares in the last quarter. Tripletail Wealth Management LLC acquired a new position in Alphabet during the third quarter worth about $40,000. WestEnd Advisors LLC boosted its position in Alphabet by 58.7% during the second quarter. WestEnd Advisors LLC now owns 165 shares of the information services provider's stock worth $29,000 after acquiring an additional 61 shares during the last quarter. Finally, University of Illinois Foundation purchased a new stake in Alphabet during the 2nd quarter valued at about $31,000. Institutional investors and hedge funds own 27.26% of the company's stock. Get Alphabet alerts: Sign Up Insiders Place Their Bets In other news, major shareholder 2017 Gp L.L.C. Gv sold 1,845,308 shares of the firm's stock in a transaction that occurred on Friday, January 30th. The shares were sold at an average price of $19.00, for a total value of $35,060,852.00. The transaction was disclosed in a document filed with the Securi...